Xenetic Biosciences Appoints Industry Veteran Mark Leuchtenberger As Chairman Of The Board Of Directors
5/5/2014 9:20:38 AM
LEXINGTON, Mass., May 5, 2014 (GLOBE NEWSWIRE) -- Xenetic Biosciences, Inc. (OTCBB:XBIO), a biopharmaceutical company developing next-generation biologic drugs and novel oncology therapeutics, today announced the appointment of Mark Leuchtenberger as Non-Executive Chairman of the Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
comments powered by